The Food and Drug Administration (FDA) Medical Countermeasures Initiative (MCMi) program has been updated for Fiscal Year 2016. The FDA continues its ongoing work to advance the development and availability of medical countermeasures to protect against chemical, biological, radiological, and nuclear (CBRN) threats. This report covers these activities, including medical countermeasure-related regulatory science, legal actions, and policy actions.
https://www.fda.gov/downloads/EmergencyPreparedness/Counterterrorism/MedicalCountermeasures/AboutMCMi/UCM546894.pdf